Selective gene therapy for proliferative disorders: sense and antisense.
Indolfi
C
C
Division of Cardiology, Federico II University, Naples, Italy.
Chiariello
M
M
Avvedimento
E V
EV
D000818:Animals; D001161:Arteriosclerosis / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D002455:Cell Division / Q000187:drug effects*; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D011905:Genes, ras; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D051379:Mice; D008954:Models, Biological; D009369:Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology* / Q000627:therapeutic use; D017346:Protein Serine-Threonine Kinases / Q000187:drug effects; D011518:Proto-Oncogene Proteins / Q000187:drug effects; D019908:Proto-Oncogene Proteins c-raf; D012333:RNA, Messenger / Q000187:drug effects; D015398:Signal Transduction / Q000502:physiology
D016376:Oligonucleotides, Antisense; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D000242:Cyclic AMP; D017346:Protein Serine-Threonine Kinases; D019908:Proto-Oncogene Proteins c-raf; D017868:Cyclic AMP-Dependent Protein Kinases